{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:24Z","timestamp":1789506624302,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128962","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:10:47Z","timestamp":1784833847000},"page":"128962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine"],"prefix":"10.1016","volume":"88","author":[{"given":"Wen-Chien","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralimanohara S.T.","family":"Murala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaurya","family":"Dumka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy E.","family":"Sayedahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128962_bb0005","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2336357","article-title":"Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines","volume":"20","author":"Russell","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128962_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.10.015","article-title":"Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza a viruses","volume":"55","author":"Moin","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128962_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/376092a0","article-title":"Structure of influenza virus haemagglutinin complexed with a neutralizing antibody","volume":"376","author":"Bizebard","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128962_bb0020","article-title":"Progress towards the development of a universal influenza vaccine","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128962_bb0025","doi-asserted-by":"crossref","first-page":"eade4790","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128962_bb0030","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2022.03.063","article-title":"Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates","volume":"40","author":"Flynn","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128962_bb0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025607119","article-title":"A single-shot vaccine approach for the universal influenza A vaccine candidate M2e","volume":"119","author":"Kavishna","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128962_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13050494","article-title":"Bovine adenoviral vector-based platform for vaccine development","volume":"13","author":"Sayedahmed","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128962_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgm.1530","article-title":"Creation of a panel of vectors based on ape adenovirus isolates","volume":"13","author":"Roy","year":"2011","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2026.128962_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.omtm.2018.07.007","article-title":"A bovine adenoviral vector-based H5N1 influenza -vaccine provides enhanced immunogenicity and protection at a significantly low dose","volume":"10","author":"Sayedahmed","year":"2018","journal-title":"Mol Ther Methods Clin Dev."},{"key":"10.1016\/j.vaccine.2026.128962_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2009.01.008","article-title":"Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model","volume":"386","author":"Sharma","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128962_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virusres.2010.07.021","article-title":"Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model","volume":"153","author":"Sharma","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2026.128962_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128962_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102594","article-title":"A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets","volume":"36","author":"Wang","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.vaccine.2026.128962_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.omtm.2023.06.009","article-title":"Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine","volume":"30","author":"Sayedahmed","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.vaccine.2026.128962_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12020157","article-title":"Development of NP-based universal vaccine for influenza A viruses","volume":"12","author":"Sayedahmed","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128962_bb0085","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza a virus nucleoprotein is a major target antigen for cross-reactive anti-influenza a virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128962_bb0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128962_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/intimm\/12.1.91","article-title":"Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge","volume":"12","author":"Epstein","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4049\/jimmunol.1800979","article-title":"Memory T cell dynamics in the lung during influenza virus infection","volume":"202","author":"Pizzolla","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2026.128962_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2024.101397","article-title":"Tissue-resident memory T cells in protective immunity to influenza virus","volume":"65","author":"Lee","year":"2024","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0120","doi-asserted-by":"crossref","first-page":"10368","DOI":"10.1038\/s41467-024-54620-4","article-title":"A vaccine platform targeting lung-resident memory CD4(+) T-cells provides protection against heterosubtypic influenza infections in mice and ferrets","volume":"15","author":"Ko","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128962_bb0125","first-page":"818","article-title":"Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza a viruses that are directed toward the nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128962_bb0130","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"Lamere","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0135","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1128\/JVI.76.12.5882-5892.2002","article-title":"Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted","volume":"76","author":"van Olphen","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-9065-8_9","article-title":"Current use of adenovirus vectors and their production methods","volume":"1937","author":"Sayedahmed","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0145","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2010.134","article-title":"An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector","volume":"5","author":"Zhou","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2026.128962_bb0150","article-title":"Adenoviral vector-based vaccine expressing hemagglutinin stem region with autophagy-inducing peptide confers cross-protection against group 1 and 2 influenza a viruses","volume":"13","author":"Wang","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128962_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41541-025-01198-7","article-title":"A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants","volume":"10","author":"Alhashimi","year":"2025","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.vaccine.2026.128962_bb0160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice","volume":"367","author":"Hoelscher","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128962_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41586-024-08054-z","article-title":"The global H5N1 influenza panzootic in mammals","volume":"637","author":"Peacock","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128962_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0140-6736(13)61207-6","article-title":"Human infection with avian influenza a H7N9 virus: an assessment of clinical severity","volume":"382","author":"Yu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128962_bb0175","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41564-025-02002-x","article-title":"Genetic diversity of H9N2 avian influenza viruses in poultry across China and implications for zoonotic transmission","volume":"10","author":"Yang","year":"2025","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1126\/science.adr5866","article-title":"Stop H5N1 influenza in US cattle now","volume":"385","author":"Lewis","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128962_bb0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","article-title":"Pathogenicity and transmissibility of bovine H5N1 influenza virus","volume":"633","author":"Eisfeld","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128962_bb0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41579-024-01087-1","article-title":"Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns","volume":"22","author":"Neumann","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0195","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41586-024-08254-7","article-title":"A human isolate of bovine H5N1 is transmissible and lethal in animal models","volume":"636","author":"Gu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128962_bb0200","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2008.12","article-title":"Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus","volume":"16","author":"Singh","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2026.128962_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/imcb.12312","article-title":"The protective potential of fc-mediated antibody functions against influenza virus and other viral pathogens","volume":"98","author":"Vanderven","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128962_bb0215","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/eji.201041225","article-title":"Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection","volume":"42","author":"Schmitz","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0220","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza a virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/266052a0","article-title":"Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells","volume":"266","author":"Virelizier","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128962_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s44298-024-00051-3","article-title":"Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?","volume":"2","author":"L\u00f3pez-Mu\u00f1oz","year":"2024","journal-title":"Npj Viruses"},{"key":"10.1016\/j.vaccine.2026.128962_bb0235","doi-asserted-by":"crossref","first-page":"e0164622","DOI":"10.1128\/jvi.01646-22","article-title":"Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza a viruses","volume":"97","author":"Rijnink","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0240","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40425-014-0029-x","article-title":"The role of fc gamma receptors in the activity of immunomodulatory antibodies for cancer","volume":"2","author":"Stewart","year":"2014","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.vaccine.2026.128962_bb0250","series-title":"Antibody Fc","first-page":"1","article-title":"Chapter 1 - antibody-dependent cellular cytotoxicity (ADCC)","author":"G\u00f3mez Rom\u00e1n","year":"2014"},{"key":"10.1016\/j.vaccine.2026.128962_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124677","article-title":"A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells","volume":"10","author":"Simhadri","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128962_bb0260","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0265","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3389\/fimmu.2019.01457","article-title":"Influenza and antibody-dependent cellular cytotoxicity","volume":"10","author":"Von Holle","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ni.2038","article-title":"Origins of CD4(+) effector and central memory T cells","volume":"12","author":"Pepper","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2016.11.011","article-title":"Tissue resident memory T cells and viral immunity","volume":"22","author":"Rosato","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coviro.2017.11.001","article-title":"Formation and function of tissue-resident memory T cells during viral infection","volume":"28","author":"Shin","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0285","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128962_bb0290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41385-018-0017-4","article-title":"IL-1\u03b2 as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza a viruses","volume":"11","author":"Lapuente","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-50345-6","article-title":"Cytomegalovirus vaccine vector-induced effector memory CD4+T cells protect cynomolgus macaques from lethal aerosolized heterologous avian influenza challenge","volume":"15","author":"Malouli","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128962_bb0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.0105-2896.2006.00394.x","article-title":"Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity","volume":"211","author":"Selin","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2026.128962_bb0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-024-00952-7","article-title":"Sequential immunization with chimeric hemagglutinin \u0394NS1 attenuated influenza vaccines induces broad humoral and cellular immunity","volume":"9","author":"Rathnasinghe","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128962_bb0310","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1084\/jem.186.12.2063","article-title":"Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice","volume":"186","author":"Graham","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128962_bb0315","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1128\/JVI.76.23.12388-12393.2002","article-title":"Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice","volume":"76","author":"Belz","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0320","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1128\/JVI.01847-14","article-title":"Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus","volume":"88","author":"Guo","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0325","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1128\/JVI.01211-16","article-title":"Influenza a virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung","volume":"90","author":"Talker","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128962_bb0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.clpt.6100418","article-title":"New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice","volume":"82","author":"Hoelscher","year":"2007","journal-title":"Clin Pharmacol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:32:33Z","timestamp":1789504353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0264410X26007711"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128962","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128962"}}